The key difference is in dosing, as tirzepatide escalation starts at 2.5mg rather than 0.25mg, which means much larger weekly doses and faster vial consumption
This is the pre-blended format, a single lyophilised vial co-formulated with BPC-157 5mg and TB-500 5mg, 10mg of total peptide under batch UKPL-855
For more on recognizing degradation, check the peptide expiration guide
Pro Tip: Always verify the benzyl alcohol concentration on the product label before use
Phase 3 trials are currently ongoing and will provide data on longer treatment durations, maintenance protocols, and discontinuation outcomes specific to retatrutide
Listing could make BPC-157 easier to obtain through US compounding pharmacies, but access is not evidence or FDA approval